← FDA DRUG APPROVALS

FDA ANDA · ANDA075555

PEMOLINE

Sponsor: TEVA PHARMS

APPLICATION
ANDA075555
TYPE
ANDA
ORIGINAL APPROVAL
2000-02-18
LATEST ACTION
2001-10-10
ROUTE
ORAL
DOSAGE FORM
TABLET, CHEWABLE
MARKETING STATUS
Discontinued

Products

PEMOLINEDiscontinued
PEMOLINE 37.5MG · TABLET, CHEWABLE · ORAL

Approval history

2001-10-10Manufacturing (CMC) · Supplement 6AP
2001-10-10Manufacturing (CMC) · Supplement 4AP
2001-10-10Manufacturing (CMC) · Supplement 5AP
2000-12-07Manufacturing (CMC) · Supplement 2AP
2000-12-07Manufacturing (CMC) · Supplement 3AP
2000-12-07Manufacturing (CMC) · Supplement 1AP
2000-02-18OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →